LumiraDx Investor Presentation Deck
LumiraDx Today:
Transforming Community-based Healthcare
Next Generation POC(¹)
Diagnostic Company
Large Installed Base with
Global Commercial Reach
Manufacturing
Designed for Scale
Broad Menu and Pipeline
of Diagnostic Tests
Experienced
Management Team
lumiraDx™
Addressing the current limitations of legacy POC systems by bringing lab-comparable performance
to the POC in minutes, a broad menu of tests on a single instrument, and a low cost of ownership
25,000+ instruments shipped to 105 countries across primary care, pharmacy, hospital emergency
departments, global health, and other settings
All current and future POC tests are developed on common strip design, enabling flexible, automated and
low-cost manufacturing on a single line. Current manufacturing capacity of 28 million test strips per month
Regulatory clearance for 12 tests for use on our Platform, with global TAM of $5B+ (excluding COVID). (2)
50+ assays in three-year roadmap
Fourth POC company for founding team. Management team has a successful track record
of diagnostic innovation and building / scaling companies in POC
(1) "POC" means point of care.
(2) Global Total Addressable Market ("TAM"): We estimate each test based on our current assumptions, including (a) the existing market sizes, (b) central lab market that could
move to POC; and (c) expansion of diagnostic testing.
Copyright © 2023 LumiraDx Ltd. All Rights Reserved, Worldwide.View entire presentation